MENLO PARK, Calif.--(BUSINESS WIRE)-- Octave® Bioscience, Inc., a leading precision care company that delivers a new standard for managing multiple sclerosis (MS) and other neurodegenerative diseases, ...
OCTAVE-DUO Study To Evaluate Novavax' Vaccine Candidate In Participants With Impaired Immune Systems
(RTTNews) - Novavax, Inc. (NVAX) said its recombinant nanoparticle protein vaccine candidate is being studied in OCTAVE-DUO in the UK to evaluate the safety and immunogenicity of a third COVID-19 ...
A new clinical trial to determine whether a third dose of vaccine will improve the immune response for people who have weakened immune systems is launching in the UK. The study, OCTAVE DUO, will offer ...
NEW YORK, NY, May 09, 2023 (GLOBE NEWSWIRE) -- Violet, the first health equity platform, released a new case study today with national behavioral health practice Octave, showing the results of care ...
OXFORD, England--(BUSINESS WIRE)--PsiOxus Therapeutics Ltd. (PsiOxus), the immuno-oncology company, today announced the first treatment of a patient to combine paclitaxel with the oncolytic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback